2025
A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial.
Zane L, Yee L, Chang T, Sklar J, Yang G, Wen J, Li P, Harrington R, Sims D, Harper K, Trent J, LoBello J, Szelinger S, Benson K, Zeng J, Poorman K, Xu D, Frampton G, Pavlick D, Miller V, Tandon B, Swat W, Weiss L, Funari V, Conroy J, Prescott J, Chandra P, Ma C, Champion K, Baschkopf G, Fesko Y, Freitas T, Tomlins S, Hovelson D, White K, Sorrells S, Tell R, Beaubier N, King D, Li L, Kelly K, Uvalic J, Meyers B, Kolhe R, Lindeman N, Baltay M, Sholl L, Lopategui J, Vail E, Zhang W, Telatar M, Afkhami M, Hsiao S, Mansukhani M, Adams E, Jiang L, Aldape K, Raffeld M, Xi L, Stehr H, Segal J, Aisner D, Davies K, Brown N, Livingston R, Konnick E, Song W, Solomon J, Walther Z, McShane L, Harris L, Chen A, Tsongalis G, Hamilton S, Flaherty K, O'Dwyer P, Conley B, Patton D, Iafrate A, Williams P, Tricoli J, Karlovich C. A Concordance Study Among 26 NGS Laboratories Participating in the National Cancer Institute-Molecular Analysis for Therapy Choice (NCI-MATCH) Clinical Trial. Clinical Cancer Research 2025 PMID: 40465838, DOI: 10.1158/1078-0432.ccr-24-2188.Peer-Reviewed Original ResearchVariant detectionVariant reportingEstimates of copy numberTarget enrichment methodLow-complexity regionsCentral laboratoryNational Cancer Institute-Molecular AnalysisNCI-MATCH trialVariant interpretationVariant classesCopy numberBioinformatics analysisCNV reporterNGS assayCLIA-certified laboratoryEnrichment methodNGSHybridization captureIndelsNCI-MATCHTumor profiling testsCell linesTherapy choiceClinical samplesSNVsMapping the Relationships between Dimensions of Child Anxiety, Parental Anxiety, and Family Accommodation: A Network Analysis
Macul Ferreira de Barros P, Farhat L, Polga N, Leckman J, Miguel E, Lebowitz E. Mapping the Relationships between Dimensions of Child Anxiety, Parental Anxiety, and Family Accommodation: A Network Analysis. Child Psychiatry & Human Development 2025, 1-8. PMID: 40146497, DOI: 10.1007/s10578-025-01831-5.Peer-Reviewed Original ResearchFamily accommodationAnxiety dimensionsSeparation anxietyParental anxietyMaintenance of child anxietyAssociated with separation anxietyPrimary anxiety disorderAnxiety disordersSocial anxietyChild anxietyAnxietyParental factorsClinical samplesChildrenDisordersAge groupsNetwork comparisonNetwork analysisRelationshipDimensionsCluster analysisParentsFamilyAccommodationKleptomania on the impulsive–compulsive spectrum. Clinical and therapeutic considerations for women
Munguía L, Baenas-Soto I, Granero R, Fábregas-Balcells M, Gaspar-Pérez A, Rosinska M, Potenza M, Cuquerella Á, Tapia-Martínez J, Cabús-Grange R, Taranilla-Castro A, Macharé-Alberni M, Talón-Navarro M, Fernández-Aranda F, Jiménez-Murcia S. Kleptomania on the impulsive–compulsive spectrum. Clinical and therapeutic considerations for women. Scientific Reports 2025, 15: 7886. PMID: 40050325, PMCID: PMC11885670, DOI: 10.1038/s41598-025-85705-9.Peer-Reviewed Original ResearchConceptsImpulsive-compulsive spectrumDSM-5 criteriaClinical groupsDSM-5Personality featuresSemi-structured clinical interviewTreatment outcomesHarm avoidance scoresCognitive behavioral treatmentHealthy control individualsSample of female patientsImpact treatment outcomesPoor treatment outcomesCompulsive featuresBehavioral treatmentHigher impulsivityAvoidance scoresClinical interviewKleptomaniaInvestigate treatment outcomesCharacteristics of peopleFemale participantsPsychopathologyClinical samplesTreatment approachesRepetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding
Michel A, Kang D, Fillingim R, Balderston N, Bond D, Steele V. Repetitive Transcranial Magnetic Stimulation for Substance Use Disorders and Chronic Pain: a Review of the Evidence and Call for Increased Mechanistic Understanding. Current Addiction Reports 2025, 12: 14. DOI: 10.1007/s40429-025-00620-3.Peer-Reviewed Original ResearchSubstance use disordersChronic painRepetitive transcranial magnetic stimulationTranscranial magnetic stimulationDiverse chronic pain conditionsChronic pain conditionsCo-occurring diseasesRTMS interventionMagnetic stimulationMagnetic resonance imagingEffective interventionsPain fieldPain conditionsSubstance use disorders fieldRepetitive transcranial magnetic stimulation applicationPainEffective treatmentUse disorderNarrative reviewClinical populationsSubstance useResonance imagingInterventionEvaluate relative efficacyClinical samplesOpioid Addiction and Gender Role Conflict: A Comparative Study of Fathers Receiving Treatment for an Opioid Use Disorder
McMahon T. Opioid Addiction and Gender Role Conflict: A Comparative Study of Fathers Receiving Treatment for an Opioid Use Disorder. Psychology Of Men & Masculinity 2025, 26: 61-75. DOI: 10.1037/men0000473.Peer-Reviewed Original ResearchGender role conflictUse disorderOpioid use disorderRole conflictOpioid addictionClinical groupsClinical sample of menRestrictive affectionate behaviorPsychology of menDrug use disordersEthnically diverse sampleSample of menRestrictive emotionalityAffectionate behaviorAnalysis of covarianceEmotional expressionParenting interventionsDiverse sampleInterpersonal relationsClinical samplesAddictionDisordersMasculinity constructsDemographic characteristicsMultinomial logistic analysis
2024
Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples
Liu Y, Yang M, Fraser K, Graham D, Weinreb P, Weihofen A, Hirst W, Cedarbaum J, Pepinsky B. Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples. Journal Of Pharmacology And Experimental Therapeutics 2024, 392: 100003. PMID: 39892989, DOI: 10.1124/jpet.124.002199.Peer-Reviewed Original ResearchCentral nervous systemCerebrospinal fluidMeso Scale DiscoveryCentral nervous system compartmentDrug concentrationsA-synCerebrospinal fluid samplesParkinson's diseasePassive immunotherapy approachesSite of actionImmunotherapy approachesLow drug concentrationsImmunotherapy trialsHealthy volunteersSystemic compartmentDrug-target interactionsCSF samplesObserved doseNervous systemTherapeutic targetA-syn levelsClinical samplesTime-dependent bindingComplex formationCross-linking methodSpanish Validation of the Brief Pornography Screen Within a Clinical Sample of Individuals with Gambling Disorder
Tarragón E, Testa G, Granero R, Potenza M, Kraus S, Uríszar J, Chiclana Actis C, Fernández-Aranda F, Jiménez-Murcia S, Mestre-Bach G. Spanish Validation of the Brief Pornography Screen Within a Clinical Sample of Individuals with Gambling Disorder. Archives Of Sexual Behavior 2024, 53: 3759-3768. PMID: 39358592, DOI: 10.1007/s10508-024-02986-3.Peer-Reviewed Original ResearchBrief Pornography ScreenProblematic pornography useClinical sample of individualsConfirmatory factor analysisGambling disorderSample of individualsPsychometric propertiesLow self-directednessOne-factor solutionAdequate psychometric propertiesClinical samplesGeneral psychopathologySelf-directednessBehavioral addictionsImpulsive tendenciesConvergent validityPornography usePsychological distressScreening instrumentSpanish versionSpanish validationFactor analysisBriefDisordersIndividuals2.49 Climate Distress: An Analysis of Risk Factors and Functional Impairment in a Clinical Sample of Young People
Wortzel J. 2.49 Climate Distress: An Analysis of Risk Factors and Functional Impairment in a Clinical Sample of Young People. Journal Of The American Academy Of Child & Adolescent Psychiatry 2024, 63: s199. DOI: 10.1016/j.jaac.2024.08.148.Peer-Reviewed Original ResearchThe relationship between momentary experiential avoidance and anxiety symptoms
Sain K, Lord K, Knowles K, Everhardt K, Tolin D. The relationship between momentary experiential avoidance and anxiety symptoms. Anxiety Stress & Coping 2024, 38: 193-205. PMID: 39104256, DOI: 10.1080/10615806.2024.2383769.Peer-Reviewed Original ResearchEcological momentary assessmentExperiential avoidanceAnxiety-related disordersAnxiety symptomsClinical sample of participantsSample of treatment-seeking patientsAssociated with greater anxietyAnxiety-related psychopathologySocial anxiety disorderBidirectional relationshipTreatment-seeking patientsTrend-level associationsSample of participantsIn-the-momentNonclinical undergraduatesAnxiety disordersMomentary assessmentGreater anxietyPerceived stressAnxietyBaseline assessmentClinical samplesDisordersTime pointsAssessment periodThe Imperfect Yet Valuable Difficulties in Emotion Regulation Scale: Factor Structure, Dimensionality, and Possible Cutoff Score
Erez C, Gordon I. The Imperfect Yet Valuable Difficulties in Emotion Regulation Scale: Factor Structure, Dimensionality, and Possible Cutoff Score. Assessment 2024, 32: 778-795. PMID: 39054870, DOI: 10.1177/10731911241261168.Peer-Reviewed Original ResearchEmotion Regulation ScaleEmotion regulationRegulation ScaleCutoff scoreDERS total scoreAssess emotion regulationER difficultiesSelf-reported dataBifactor modelUnidimensional solutionFactor structureTotal scoreSelf-reportLife satisfactionPsychopathologyClinical samplesEmotionsGroup interactionMultidimensional scalingScoresBifactorScaleDifficultiesSubfactorsPersonsThe Development of a Novel Scale to Assess Intra- and Interpersonal Emotion Regulation Strategies: The Emotion Regulation Strategy Scale (ERSS)
Kneeland E, Hay A, Curtiss J, Hennessey A, Vanderlind W, Joormann J, Clark M. The Development of a Novel Scale to Assess Intra- and Interpersonal Emotion Regulation Strategies: The Emotion Regulation Strategy Scale (ERSS). Emotion 2024, 24: 1582-1599. PMID: 38829352, DOI: 10.1037/emo0001375.Peer-Reviewed Original ResearchEmotion Regulation Strategies ScaleEmotion regulation strategiesInterpersonal emotion regulation strategiesRegulation strategiesConfirmatory factor analysisEmotion regulationStudy 3Specific emotion regulation strategiesLevels of clinical symptomsEmotion regulation researchEmotion Regulation ScaleFactor analysisIntra-personalNine-factor solutionInterpersonal scalesCognitive reappraisalRegulation ScaleExpressive suppressionSituation selectionStudy 1Study 2Scale itemsRegulation researchEmotionsClinical samplesPaper-based point of care diagnostics for cancer biomarkers
Bhardwaj P, Arora B, Saxena S, Singh S, Palkar P, Goda J, Banerjee R. Paper-based point of care diagnostics for cancer biomarkers. Sensors & Diagnostics 2024, 3: 504-535. DOI: 10.1039/d3sd00340j.Peer-Reviewed Original ResearchPaper-based biosensorsDetection techniquesLow detection limitDetection i.Point-of-care systemLow-cost diagnosisManagement of cancerPoint of care diagnosticsUser-friendlyHome test kitsPatient survivalDetection of cancerAnalyte detectionDiagnosis of cancerDetection limitSignal transmissionSymptomatic detectionPaper chemistryTreatment opportunitiesCancerSignal amplificationAdvanced nanomaterialsEarly detectionCancer detectionClinical samplesPsychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Sloshower J, Zeifman R, Guss J, Krause R, Safi-Aghdam H, Pathania S, Pittman B, D’Souza D. Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial. Scientific Reports 2024, 14: 8833. PMID: 38632313, PMCID: PMC11024097, DOI: 10.1038/s41598-024-58318-x.Peer-Reviewed Original ResearchConceptsPsilocybin-assisted therapyPsychological flexibilityDepression severityModerate to severe MDDSpectrum of neuropsychiatric conditionsTarget psychological flexibilityIncrease psychological flexibilityMental health conditionsManualized psychotherapyPsilocybin treatmentSevere MDDDepressive disorderExperiential acceptanceCommitment therapyDosing sessionsNeuropsychiatric conditionsPsychedelic trialsPlacebo-controlled trialWithin-subjectMDDPsilocybinAdministered placeboPlacebo-controlledDepressionClinical samplesPalm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection
Li Z, Zhang S, Zhang J, Avery L, Banach D, Zhao H, Liu C. Palm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection. Advanced Science 2024, 11: 2310066. PMID: 38634211, PMCID: PMC11187901, DOI: 10.1002/advs.202310066.Peer-Reviewed Original ResearchDetect SARS-CoV-2Molecular diagnostics of infectious diseasesMolecular diagnosticsMolecular detection of virusesSARS-CoV-2Point-of-care molecular diagnosticsDiagnostics of infectious diseasesNucleic acid extractionMolecular detection methodsViral lysisNucleic acid sample preparationSensitive molecular diagnosticsAccurate molecular diagnosticsCRISPR detectionEarly treatmentSensitive virus detectionDetection of virusesClinical utilityNucleic acid amplificationHIV virusEarly treatment of diseaseIsothermal amplificationMagnetic beadsMicrocentrifuge tubesClinical samplesIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie International Edition 2024, 63: e202403123. PMID: 38516796, PMCID: PMC11073899, DOI: 10.1002/anie.202403123.Peer-Reviewed Original ResearchProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacerIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie 2024, 136 DOI: 10.1002/ange.202403123.Peer-Reviewed Original ResearchProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacerLifetime history of childhood adversity and substance abuse in patients with treatment resistant depression
Giampetruzzi E, McDonald W, Rice H, Kitay B, Hermida A, Posse P, Hershenberg R. Lifetime history of childhood adversity and substance abuse in patients with treatment resistant depression. Personalized Medicine In Psychiatry 2024, 43: 100122. DOI: 10.1016/j.pmip.2024.100122.Peer-Reviewed Original ResearchTreatment-resistant depressionAdverse childhood experiencesHistory of substance abuseSubstance abuseDepressive disorderAssociated with treatment-resistant depressionTreatment-resistant depressed patientsPersistent depressive disorderLifetime substance abuseEffects of adverse childhood experiencesRisk of substance abuseAssociation of adverse childhood experiencesACE subtypesACE exposureResistant depressionLifetime historyChildhood adversityChildhood experiencesAbuseClinical samplesDepressionDisordersLogistic regression analysisMDDSubstancesPrecision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers
Lin D, Huang R, Ladas I, Keller R, Patel N, Lakis S, Decker B, Janovitz T, Mata D, Ross J, Vergilio J, Elvin J, Herbst R, Mack P, Killian J. Precision needle-punch tumor enrichment from paraffin blocks improves the detection of clinically actionable genomic alterations and biomarkers. Frontiers In Oncology 2024, 14: 1328512. PMID: 38444675, PMCID: PMC10912171, DOI: 10.3389/fonc.2024.1328512.Peer-Reviewed Original ResearchTumor mutational burdenTumor purityTumor specimensNext-generation sequencingClinically actionable genomic alterationsMicrosatellite instabilityBiomarker statusTissue-conserving methodTissue blocksHigh tumor purityLow tumor purityComplex biomarkersSurgical pathology materialClinical samplesClinical trial enrollmentVariant allele frequencyResidual tumorMutational burdenTumor enrichmentTumor contentTumor cellsGenomic alterationsFormalin-fixedParaffin blocksDetect mutationsGeneralized anxiety and mild anxiety symptoms in U.S. military veterans: Prevalence, characteristics, and functioning
Macdonald-Gagnon G, Stefanovics E, Potenza M, Pietrzak R. Generalized anxiety and mild anxiety symptoms in U.S. military veterans: Prevalence, characteristics, and functioning. Journal Of Psychiatric Research 2024, 171: 263-270. PMID: 38325107, DOI: 10.1016/j.jpsychires.2024.02.013.Peer-Reviewed Original ResearchConceptsGeneralized anxiety disorderMild anxiety symptomsAnxiety symptomsMilitary veteransU.S. veteransCorrelates of generalized anxiety disorderCorrelates of anxiety symptomsAnxiety symptom severityU.S. military veteransAnxiety disordersGeneralized anxietyPoor mental healthSuicidal thoughtsSymptom severityMental disordersExcessive anxietyAnxietyMagnitude associationsMental healthFunctional impairmentVeteransFunctional correlatesClinical samplesNationally representative sampleSymptomsThe effect of ABM on attentional networks and stress-induced emotional reactivity in a mixed clinical sample with depression: A randomized sham-controlled trial
Bø R, Kraft B, Jonassen R, Joormann J, Harmer C, Landrø N. The effect of ABM on attentional networks and stress-induced emotional reactivity in a mixed clinical sample with depression: A randomized sham-controlled trial. Neuroscience Applied 2024, 3: 104091. DOI: 10.1016/j.nsa.2024.104091.Peer-Reviewed Original ResearchAttention Network TaskEmotional reactivityAttention networkEfficacy of attentional bias modificationAttentional bias modificationExecutive attention networkEffect of AbMBias modificationComorbid anxietyLab stressorDepressive disorderAttentional processesDepressive symptomsMinimal effect sizeDepression scoresNetwork tasksEffect sizeSham-controlled trialRandomized sham-controlled trialClinical samplesSham comparatorTwo-weekRandomized controlled trialsParticipantsAnxiety
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply